Palmitoyl Tripeptide-1 | CAS:147732-56-7

We serve Palmitoyl Tripeptide-1 CAS:147732-56-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Palmitoyl Tripeptide-1

Chemical Name:Palmitoyl Tripeptide-1
CAS.NO:147732-56-7
Synonyms:Palmitoyl Tripeptide-1
N2-[N-[N-(1-oxohexadecyl)glycyl]-L-histidyl]-L-lysine
N-Palmitoylglycyl-L-histidyl-L-lysine
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 913.0±65.0 °C at 760 mmHg
Molecular Formula C30H54N6O5
Molecular Weight 578.787
Flash Point 506.0±34.3 °C
Vapour Pressure 0.0±0.3 mmHg at 25°C
Index of Refraction 1.524
 
Specification:
Appearance:White powder
Assay:≥95%
Moisture:≤5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Stimulates the replenishment of the matrix of the skin leading to wrinkle reduction.



Contact us for information like Palmitoyl Tripeptide-1 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-Palmitoylglycyl-L-histidyl-L-lysine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-Palmitoylglycyl-L-histidyl-L-lysine Use and application,N2-[N-[N-(1-oxohexadecyl)glycyl]-L-histidyl]-L-lysine technical grade,usp/ep/jp grade.


Related News: There’s a few factors that play into this.5'-Deoxy-5-fluorocytidine manufacturer Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday.2-Nitro-3-pyridinamine supplier They should also not use public transport for a fortnight after returning to Britain.4-phenylbutan-1-ol vendor Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.